x 

0 Activities
0 Activities
    • No Saved Activities

Education

  2. Home
  3. Disease Area
  4. Chronic Obstructive Pulmonary Disease (COPD)
  5. Disease Area
  6. Interstitial Lung Disease

Interstitial Lung Disease

Free online continuing education on Interstitial Lung Disease! Get quality activities, articles, & videos to improve your Interstitial Lung Disease education.

Page 1 of 2
Results 1 - 75 of 127
New Frontiers in the Treatment of DMD Across the Age Spectrum
Future Horizons for Fibrosing ILDs: A Focus on IPF and PPF
9630-ild
Improving the Diagnosis and Management of PPF: Rapid Recap
9630-ild
Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF
9360-0001_263x149
Improving the Management of Patients with PPF - Slide Library
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Rapid Recap
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis - Slide Deck
9260-child
Providing a Medical Home for Kids with Rare Lung Disease - Rapid Recap
MicrosoftTeams-image (18)
Coordinating Care for Patients With Progressive Pulmonary Fibrosis
9260-child
Providing a Medical Home for Kids with Rare Lung Disease
9260-child
Providing a Medical Home for Kids with Rare Lung Disease - Slide Deck
9260-activity-image-263x149
Providing a Medical Home for Kids with Rare Lung Disease - Live Meeting Recording
9259-ild_263x0
The Role of the Community Radiologist in the Care of Patients With ILDs - Rapid Recap
9194 chILD module
Childhood ILD: Increasing Awareness, Diagnosis, & Patient Management - Rapid Recap
9259-ild_263x0
The Role of the Community Radiologist in the Care of Patients With ILDs - Slide Deck
9194 chILD module
Childhood ILD: Increasing Awareness, Diagnosis, & Patient Management
9193-case3
SSc-ILD With Rapid Progression
9193-case2
Delayed Diagnosis of SSc-ILD with PPF
9193-case1
Identifying the Signs and Symptoms of PPF
9157-mod2
Treating Complex Cases of NTM-LD
9157-mod1
NTM-LD Diagnosis and Management
9157-0003-slide263x149
NTM-LD Daignosis and Management - Slide Deck
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
9088-covid-slides
Post COVID-19 and Patients With and Without Pre-existing ILD - Slide Deck
9088-ipf-slides
A Collaborative Approach to IPF Management - Slide Deck
9088-sscild-slides
Practical Solutions to SSc-ILD Treatment - Slide Deck
9088-pfild-slides8
A New Paradigm in Treating ILD - Slide Deck
No image set
A New Paradigm in Treating ILD
No image set
A Collaborative Approach to IPF Management
No image set
Practical Solutions to SSc-ILD Treatment
No image set
Post COVID-19 and Patients With and Without Pre-existing ILD
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
IPF Animated Video Series: Micro-learning focusing on the soft skills
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan to Manage IPF
No image set
Diagnosis of Interstitial Lung Disease
No image set
Management of Patients With IPF: Virtual Conference Coverage
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Learnings From the Virtual ERS International Congress
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
No image set
How to Identify & Manage Patients with Progressive-Fibrosing ILD
9840-0004-icon
Acute Exacerbations of IPF
No image set
Thoracic Radiology
No image set
A Closer Look at ILD, Sarcoidosis, and CTEPH
No image set
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
Page 1 of 2

Search